Historial de carrera de Mary Lucus
Antiguos cargos conocidos de Mary Lucus.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SELECTIS HEALTH, INC. | Comptroller/Controller/Auditor | 01/04/2021 | 05/04/2023 |
| Director Financiero/CFO | 04/03/2022 | 05/04/2023 | |
| Secretario Corporativo | 31/10/2022 | 05/04/2023 | |
| NEUBASE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Formación de Mary Lucus.
| San Diego State University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Corporate Secretary | 1 |
Sectorial
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SELECTIS HEALTH, INC. | Finance |
| Empresas privadas | 1 |
|---|---|
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on March 29, 2002 and is headquartered in Pittsburgh, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Mary Lucus
- Experiencia
